GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma

GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma

Introduction: Lenvatinib has recently become available as the first-line therapy for advanced hepatocellular carcinoma (HCC), but its molecular mechanism in HCC remains largely unknown. Objectives: The current study aims to identify the molecular mechanisms of lenvatinib in HCC. Methods: Gene expres...

Full description

Bibliographic Details
Main Authors: Wenliang Tan, Kelin Zhang, Xinming Chen, Lei Yang, Sicong Zhu, Yingcheng Wei, Zhiqin Xie, Yajin Chen, Changzhen Shang
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Journal of Advanced Research
Subjects:
Lenvatinib
GPX2
Hepatocellular carcinoma
Apoptosis
ROS
Online Access:http://www.sciencedirect.com/science/article/pii/S2090123222000741

Internet

http://www.sciencedirect.com/science/article/pii/S2090123222000741

Similar Items